COLLECTIONS
WORKFLOWS
Recent Finacing
Recent Raise
Episona develops epigenetic reproductive-health tests; its physician-ordered Seed analyzes sperm DNA methylation to assess male-factor infertility, predict embryo quality, and guide IUI/IVF decisions and donor selection.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor